Clinical Trial Update: Novel Therapeutic Approaches for Treatment of CF Patients With W1282X Premature Termination Codon Mutations [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating novel therapies for cystic fibrosis patients with the W1282X premature termination codon has been terminated, with results posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cystic Fibrosis | Phase 4 | Status: TERMINATED | Results posted: 2025-04-16